The industry-led AMR Action Fund is a major step forward in tackling the spread of drug-resistant infections. Jeremy Knox explains why governments too need to do more to stimulate antibiotic development.
Six months on from the first case of COVID-19, the pandemic is accelerating and spreading into new areas. Jeremy Farrar talks about the lessons we learned and the long-term solutions.
Recent history proves that even the deadliest viruses – like Ebola and HIV – can be made treatable, if we concentrate our efforts on research, development and access.
Developed in collaboration with our LGBTQ+ network at Wellcome, we're launching a new trans inclusion policy for our staff.
Science will show us the way out of the COVID-19 pandemic. And businesses and philanthropy can play a major role by stepping up to fund coronavirus treatments, as well as vaccines and tests.
Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.
Researchers may well identify a safe, effective vaccine for COVID-19 before too long, but all that fantastic work could count for nothing unless we also invest in the next stages of the vaccine process – manufacturing and delivery.
With measures to prevent the spread of COVID-19 disrupting immunisation around the globe, millions are now at risk of other deadly diseases. We must act and invest urgently to maintain routine immunisation.